IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,969,645 | +103.0% | 155,500 | +0.3% | 0.13% | +150.9% |
| Q2 2023 | $2,940,350 | -64.1% | 155,000 | -70.6% | 0.05% | -57.6% |
| Q1 2023 | $8,189,280 | -12.6% | 528,000 | 0.0% | 0.12% | +8.7% |
| Q4 2022 | $9,372,000 | +388.1% | 528,000 | +51.5% | 0.12% | +447.6% |
| Q1 2022 | $1,920,000 | -35.3% | 348,400 | 0.0% | 0.02% | -34.4% |
| Q4 2021 | $2,968,000 | +208.2% | 348,400 | +214.4% | 0.03% | +220.0% |
| Q3 2021 | $963,000 | – | 110,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |